Previous study has shown that RFC4 is highly expressed in cancer tissues such as hepatocellular carcinoma [15], non-small cell lung cancer (NSCLC) [45], prostate cancer [46], breast cancer [20], and cervical cancer [47]. Here, RFC4 is linked to non-small cell lung carcinoma.